(USLM) United States Lime - Overview
Stock: Limestone, Quicklime, Hydrated, Lime Slurry, Pulverized
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.22% |
| Yield on Cost 5y | 1.12% |
| Yield CAGR 5y | -21.75% |
| Payout Consistency | 45.5% |
| Payout Ratio | 5.3% |
| Risk 5d forecast | |
|---|---|
| Volatility | 47.2% |
| Relative Tail Risk | -7.10% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.02 |
| Alpha | -19.84 |
| Character TTM | |
|---|---|
| Beta | 1.138 |
| Beta Downside | 0.820 |
| Drawdowns 3y | |
|---|---|
| Max DD | 45.87% |
| CAGR/Max DD | 1.15 |
Description: USLM United States Lime January 11, 2026
United States Lime & Minerals, Inc. (NASDAQ:USLM) extracts limestone from both open-pit quarries and an underground mine, then processes it into pulverized limestone, quicklime, hydrated lime, and lime slurry. Its customer base spans construction (highway, road, and building contractors), industrial users (paper, glass), environmental services (municipal water treatment, flue-gas desulfurization), oil-field services, roof-shingle manufacturers, and poultry producers. The firm also holds royalty interests in natural-gas wells in the Barnett Shale, Texas, and operates as a subsidiary of Inberdon Enterprises Ltd.
Key operational metrics from the most recent filing show USLM generated ≈ $215 million in revenue for FY 2023, with an adjusted EBITDA margin of roughly 22 %, reflecting the high-value nature of specialty lime products. Demand is closely tied to two macro drivers: (1) U.S. infrastructure spending, which the bipartisan infrastructure law is projected to boost construction-related lime usage by 4-6 % annually through 2027; and (2) tightening environmental regulations on sulfur-oxide emissions, which have increased the market for flue-gas treatment lime by an estimated 3 % YoY. Additionally, the company’s royalty exposure to the Barnett Shale provides a modest hedge against cyclical construction demand, contributing roughly 5 % of total earnings in the last quarter.
For a deeper quantitative view, you may find ValueRay’s data platform useful for tracking USLM’s performance trends and sector benchmarks.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 134.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA -6.90 > 1.0 |
| NWC/Revenue: 115.8% < 20% (prev 106.3%; Δ 9.49% < -1%) |
| CFO/TA 0.18 > 3% & CFO 119.4m > Net Income 134.3m |
| Net Debt (6.99m) to EBITDA (186.3m): 0.04 < 3 |
| Current Ratio: 19.27 > 1.5 & < 3 |
| Outstanding Shares: last quarter (28.7m) vs 12m ago 0.15% < -2% |
| Gross Margin: 48.91% > 18% (prev 0.45%; Δ 4846 % > 0.5%) |
| Asset Turnover: 60.89% > 50% (prev 58.49%; Δ 2.40% > 0%) |
| Interest Coverage Ratio: -3.01 > 6 (EBITDA TTM 186.3m / Interest Expense TTM -42.7m) |
Altman Z'' 10.00
| A: 0.63 (Total Current Assets 455.3m - Total Current Liabilities 23.6m) / Total Assets 681.0m |
| B: 0.90 (Retained Earnings 614.2m / Total Assets 681.0m) |
| C: 0.21 (EBIT TTM 128.4m / Avg Total Assets 612.1m) |
| D: 12.54 (Book Value of Equity 630.8m / Total Liabilities 50.3m) |
| Altman-Z'' Score: 21.68 = AAA |
What is the price of USLM shares?
Over the past week, the price has changed by -9.94%, over one month by -14.77%, over three months by -4.97% and over the past year by -2.41%.
Is USLM a buy, sell or hold?
- StrongBuy: 0
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the USLM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 125 | 15.2% |
| Analysts Target Price | 125 | 15.2% |
| ValueRay Target Price | 149 | 37.2% |
USLM Fundamental Data Overview February 07, 2026
P/S = 8.2216
P/B = 5.2111
Revenue TTM = 372.7m USD
EBIT TTM = 128.4m USD
EBITDA TTM = 186.3m USD
Long Term Debt = unknown (none)
Short Term Debt = 1.64m USD (from shortTermDebt, two quarters ago)
Debt = 6.99m USD (from shortLongTermDebtTotal, two quarters ago)
Net Debt = 6.99m USD (using Total Debt 6.99m, CCE unavailable)
Enterprise Value = 3.41b USD (3.40b + Debt 6.99m - (null CCE))
Interest Coverage Ratio = -3.01 (Ebit TTM 128.4m / Interest Expense TTM -42.7m)
EV/FCF = 44.45x (Enterprise Value 3.41b / FCF TTM 76.6m)
FCF Yield = 2.25% (FCF TTM 76.6m / Enterprise Value 3.41b)
FCF Margin = 20.56% (FCF TTM 76.6m / Revenue TTM 372.7m)
Net Margin = 36.03% (Net Income TTM 134.3m / Revenue TTM 372.7m)
Gross Margin = 48.91% ((Revenue TTM 372.7m - Cost of Revenue TTM 190.4m) / Revenue TTM)
Gross Margin QoQ = 47.96% (prev 51.16%)
Tobins Q-Ratio = 5.00 (Enterprise Value 3.41b / Total Assets 681.0m)
Interest Expense / Debt = 1.83% (Interest Expense 128.0k / Debt 6.99m)
Taxrate = 22.79% (9.02m / 39.6m)
NOPAT = 99.1m (EBIT 128.4m * (1 - 22.79%))
Current Ratio = 19.27 (Total Current Assets 455.3m / Total Current Liabilities 23.6m)
Debt / Equity = 0.01 (Debt 6.99m / totalStockholderEquity, last quarter 630.8m)
Debt / EBITDA = 0.04 (Net Debt 6.99m / EBITDA 186.3m)
Debt / FCF = 0.09 (Net Debt 6.99m / FCF TTM 76.6m)
Total Stockholder Equity = 582.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 21.94% (Net Income 134.3m / Total Assets 681.0m)
RoE = 23.07% (Net Income TTM 134.3m / Total Stockholder Equity 582.1m)
RoCE = 19.52% (EBIT 128.4m / Capital Employed (Total Assets 681.0m - Current Liab 23.6m))
RoIC = 17.51% (NOPAT 99.1m / Invested Capital 565.9m)
WACC = 10.09% (E(3.40b)/V(3.41b) * Re(10.11%) + D(6.99m)/V(3.41b) * Rd(1.83%) * (1-Tc(0.23)))
Discount Rate = 10.11% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.31%
[DCF Debug] Terminal Value 74.77% ; FCFF base≈85.4m ; Y1≈105.4m ; Y5≈179.4m
Fair Price DCF = 73.88 (EV 2.12b - Net Debt 6.99m = Equity 2.12b / Shares 28.6m; r=10.09% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -55.16 | EPS CAGR: -9.32% | SUE: N/A | # QB: 0
Revenue Correlation: 91.81 | Revenue CAGR: 15.69% | SUE: N/A | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.15 | Chg30d=+0.000 | Revisions Net=+0 | Analysts=1
EPS next Year (2026-12-31): EPS=4.84 | Chg30d=+0.000 | Revisions Net=+0 | Growth EPS=+5.5% | Growth Revenue=+8.4%